(Q83525720)
Statements
Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies) (English)
Yves Vanrenterghem
Barbara Bresnahan
Josep Campistol
Antoine Durrbach
Josep Grinyó
Hans-Hellmut Neumayer
Philippe Lang
Eduardo Mancilla-Urrea
José Medina Pestana
Alan Block
Tao Duan
Alan Glicklich
Sheila Gujrathi
Flavio Vincenti